NHS Logo
As One Logo

Not approved / Named patient request drugs

Drugs Comments
Agomelatine Named patient request only. Prescribing to remain with HPFT – NOT to be transferred to primary care. Risk of dose related hepatotoxicity and liver failure see MHRA updated warning and monitoring guidance Oct 12
Asenapine NOT approved.
Escitalopram Named patient request only. Citalopram and escitalopram: QT interval prolongation - new maximum daily dose restrictions (including in elderly patients) contrainidcations and warnings: MHRA Dec 2011
Dosulepin NOT Recommended (NICE CG 90) – cardiotoxic and toxicity in overdose.
Olanzapine Embonate Named patient request only – risk of post injection syndrome. See HPFT guidance on the use Olanzapine LAI
Lurasidone NOT approved.
Melatonin NOT approved for licensed indication (Circadin®) 
NOT approved by HMMC for treatment of sleep disorders in children. Named patient request only.  Prescribing to remain with HPFT.
Paliperidone Tablets NOT approved. (Long acting injection approved) 
Risperidone Long acting injection - named patient request only (tablets approved). NO new initiations from Feb 2017. Patients commenced prior to this date can continue to receive this.
Trimipramine Removed from formulary as not a cost -effective choice of tricyclic antidepressant
Varenicline  Named patient request only. NICE -TA123 - Varenicline for smoking cessation 


Continue to Appendix - Glossary of terms


Back to Contents Page


Contact Us